Vicarious Surgical
Developer of a robotic surgical system focused on single-port minimally invasive abdominal access. The company designs an integrated platform comprising a patient-side cart and a surgeon console to enable intracorporeal robotic instrument control, immersive 3D visualization, and teleoperated surgical control. The organization also maintains on-site R&D and testing facilities and has pursued regulatory pathways including FDA Breakthrough Device designation.
Industries
Nr. of Employees
medium (51-250)
Vicarious Surgical
Waltham, Massachusetts, United States
Patents
System and method for determining depth perception in vivo in a surgical robotic system
US-12731278-B2
View DetailsCamera assembly comprising a camera support tube having a distal end and a proximal end
US-12611262-B2
View DetailsSystem and method for exchanging surgical tools in an implantable surgical robotic system
US-12383353-B2
View Details
System and method for determining depth perception in vivo in a surgical robotic system
US-12731278-B2
View DetailsCamera assembly comprising a camera support tube having a distal end and a proximal end
US-12611262-B2
View DetailsSystem and method for exchanging surgical tools in an implantable surgical robotic system
US-12383353-B2
View DetailsProducts
Robotic surgical system for single-port abdominal access
Integrated surgical platform composed of a patient-side cart and a surgeon console that enables intracorporeal robotic instrument control, immersive 3D visualization, and teleoperated control through a single small incision.
Vicarious Surgical Robotic System
A single-port surgical robot system designed for abdominal access and visualization through a small 1.5 cm incision, featuring human-inspired motion and complete 360-degree visibility.
Robotic surgical system for single-port abdominal access
Integrated surgical platform composed of a patient-side cart and a surgeon console that enables intracorporeal robotic instrument control, immersive 3D visualization, and teleoperated control through a single small incision.
Vicarious Surgical Robotic System
A single-port surgical robot system designed for abdominal access and visualization through a small 1.5 cm incision, featuring human-inspired motion and complete 360-degree visibility.
Services
Collaboration with hospitals and research centers to evaluate and advance the robotic platform.
Internal facility including a full-scale operating room for robotics testing and clean-room space to support prototype testing and manufacturing scale-up.
Collaboration with hospitals and research centers to evaluate and advance the robotic platform.
Internal facility including a full-scale operating room for robotics testing and clean-room space to support prototype testing and manufacturing scale-up.
Expertise Areas
- Surgical robotics
- Single-port minimally invasive surgery
- Intracorporeal instrument actuation
- Surgical visualization and imaging
Key Technologies
- 3D stereoscopic imaging
- Teleoperated surgical consoles
- Intracorporeal robotic actuation
- Human-motion-inspired kinematic control
News & Updates
Leased a 42,000 sq. ft. facility in Waltham to house a full-scale operating room for robotics testing as well as R&D and company operations; expansion includes clean-room space for manufacturing.
Appointment of an executive who led establishment of partnerships with hospitals and research centers.
Appointment of William J. Kelly, CPA as Chief Financial Officer and June M. Morris, Esq. as General Counsel and Chief Legal Officer.
Qualified for an FDA Breakthrough Device Designation to support priority review and regulatory engagement for the robotic system.
Company discussed SPAC merger activity and intends to trade on Nasdaq under the ticker RBOT after merging with D8 Holdings Corp.
Leased a 42,000 sq. ft. facility in Waltham to house a full-scale operating room for robotics testing as well as R&D and company operations; expansion includes clean-room space for manufacturing.
Appointment of an executive who led establishment of partnerships with hospitals and research centers.
Appointment of William J. Kelly, CPA as Chief Financial Officer and June M. Morris, Esq. as General Counsel and Chief Legal Officer.
Qualified for an FDA Breakthrough Device Designation to support priority review and regulatory engagement for the robotic system.
Company discussed SPAC merger activity and intends to trade on Nasdaq under the ticker RBOT after merging with D8 Holdings Corp.